BNGO Stock — Bionano Genomics Inc

Bionano Genomics Inc (BNGO)

Updated October 16, 2026.

BNGO is a Stock. Total return is -100.0% over the past 8.2 years, 301.8 points behind SPY at 201.8%.

Bionano Genomics is a San Diego-based life sciences company that develops and sells genome analysis solutions, including optical genome mapping instruments (Saphyr and Stratys systems), software platforms for genomic data analysis and interpretation, and clinical testing services for genetic disorders including autism spectrum disorder, developmental delay, and fragile X syndrome. The company operates globally across the Americas, Europe, Asia, and Africa, serving genomics laboratories and healthcare providers. We have no information on its current distribution status or frequency.

BNGO performance versus SPY

Price and return data through 2026-10-16.

Total return is -100.0% over the past 8.2 years, 301.8 points behind SPY at 201.8%. Over the past year its total return — price change plus distributions reinvested — is -37.2%. Its deepest 1-year drawdown was 46.7%.

BNGO key facts

Asset type

Stock

Asset class

Equity

Inception date

08/21/2018

Distribution frequency

None

Last close

$1.25 (as of 2026-10-16)

Market cap

$14,721,250

Average volume

180754.0

Beta

1.658

Payout ratio

0.0%

EPS

$-3.02

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BNGO risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 46.7%.

Who may consider BNGO — and who may not

It is a weaker fit for investors who need monthly cash flow (BNGO does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BNGO

• All tickers starting with B

Tagged: Healthcare.

Frequently asked questions